サマリー

標的タンパク質分解薬の世界市場規模は、2023年の100万米ドルから2030年には100万米ドルに成長すると予測されており、2024年から2030年にかけて年平均成長率%で成長すると予測されています。
LPI（エルピーアイ情報）の最新調査レポート「標的タンパク質分解薬産業予測」は、過去の売上高から2023年の標的タンパク質分解薬の世界総売上高を考察し、2024年から2030年までの標的タンパク質分解薬の売上高予測について地域別・市場分野別に包括的な分析を提供します。本レポートでは、標的タンパク質分解薬の売上高を地域別、市場分野別、サブセクター別に分類し、世界の標的タンパク質分解薬産業の詳細な分析を百万米ドル単位で提供しています。
本インサイトレポートでは、世界の標的タンパク質分解薬業界を包括的に分析し、製品セグメンテーション、企業形成、収益、市場シェア、最新動向、M&A活動などに関する主要動向を明らかにします。また本レポートでは、標的タンパク質分解薬のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要グローバル企業の戦略を分析し、加速する世界の標的タンパク質分解薬市場におけるこれらの企業の独自の地位をより深く理解しています。
本インサイトレポートでは、標的タンパク質分解薬の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に分類して予測を行い、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの定性的・定量的市場インプットに基づいた透明性の高い手法により、この調査予測は世界の標的タンパク質分解薬の現状と将来の軌道について非常にニュアンスのある見解を提供します。
標的タンパク質分解薬の米国市場は、2023年の100万米ドルから2030年までに100万米ドルに増加し、2024年から2030年までの年平均成長率は％と推定される。
標的タンパク質分解薬の中国市場は、2023年の100万米ドルから2030年には100万米ドルに、2024年から2030年までの年平均成長率は％と推定される。
標的タンパク質分解薬のヨーロッパ市場は、2023年の100万米ドルから2030年には100万米ドルに、2024年から2030年までの年平均成長率は％と推定される。
標的タンパク質分解薬の世界的な主要企業は、Arvinas、Kangpu Biopharmaceuticals、Ranok Therapeutics、Accutar Biotechnology、BeiGene Ltd.などである。売上高では、世界の大手2社が2023年にほぼ％のシェアを占めています。
この調査レポートは、標的タンパク質分解薬市場の包括的な概要、市場シェア、成長機会を、製品タイプ、用途、主要企業、主要地域および国別に掲載しています。
タイプ別セグメント
プロタック
モレキュラーグルー
用途別セグメント
癌
自己免疫疾患
その他
本レポートではまた、市場を地域別に分けています：
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
アルビナス
Kangpu Biopharmaceuticals
ラノック・セラピューティクス
アキュター・バイオテクノロジー
ベイジーン
ヒノバ・ファーマシューティカルズ
ハイスコ製薬
ヌリックス
カイメラ・セラピューティクス
C4セラピューティクス

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeted Protein Degradation Drug Market Size 2019-2030
2.1.2 Targeted Protein Degradation Drug Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Targeted Protein Degradation Drug Segment by Type
2.2.1 PROTAC
2.2.2 Molecular Glue
2.3 Targeted Protein Degradation Drug Market Size by Type
2.3.1 Targeted Protein Degradation Drug Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
2.4 Targeted Protein Degradation Drug Segment by Application
2.4.1 Cancer
2.4.2 Autoimmune Diseases
2.4.3 Other
2.5 Targeted Protein Degradation Drug Market Size by Application
2.5.1 Targeted Protein Degradation Drug Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
3 Targeted Protein Degradation Drug Market Size by Player
3.1 Targeted Protein Degradation Drug Market Size Market Share by Players
3.1.1 Global Targeted Protein Degradation Drug Revenue by Players (2019-2024)
3.1.2 Global Targeted Protein Degradation Drug Revenue Market Share by Players (2019-2024)
3.2 Global Targeted Protein Degradation Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Targeted Protein Degradation Drug by Regions
4.1 Targeted Protein Degradation Drug Market Size by Regions (2019-2024)
4.2 Americas Targeted Protein Degradation Drug Market Size Growth (2019-2024)
4.3 APAC Targeted Protein Degradation Drug Market Size Growth (2019-2024)
4.4 Europe Targeted Protein Degradation Drug Market Size Growth (2019-2024)
4.5 Middle East & Africa Targeted Protein Degradation Drug Market Size Growth (2019-2024)
5 Americas
5.1 Americas Targeted Protein Degradation Drug Market Size by Country (2019-2024)
5.2 Americas Targeted Protein Degradation Drug Market Size by Type (2019-2024)
5.3 Americas Targeted Protein Degradation Drug Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Protein Degradation Drug Market Size by Region (2019-2024)
6.2 APAC Targeted Protein Degradation Drug Market Size by Type (2019-2024)
6.3 APAC Targeted Protein Degradation Drug Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Targeted Protein Degradation Drug by Country (2019-2024)
7.2 Europe Targeted Protein Degradation Drug Market Size by Type (2019-2024)
7.3 Europe Targeted Protein Degradation Drug Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Targeted Protein Degradation Drug by Region (2019-2024)
8.2 Middle East & Africa Targeted Protein Degradation Drug Market Size by Type (2019-2024)
8.3 Middle East & Africa Targeted Protein Degradation Drug Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Targeted Protein Degradation Drug Market Forecast
10.1 Global Targeted Protein Degradation Drug Forecast by Regions (2025-2030)
10.1.1 Global Targeted Protein Degradation Drug Forecast by Regions (2025-2030)
10.1.2 Americas Targeted Protein Degradation Drug Forecast
10.1.3 APAC Targeted Protein Degradation Drug Forecast
10.1.4 Europe Targeted Protein Degradation Drug Forecast
10.1.5 Middle East & Africa Targeted Protein Degradation Drug Forecast
10.2 Americas Targeted Protein Degradation Drug Forecast by Country (2025-2030)
10.2.1 United States Targeted Protein Degradation Drug Market Forecast
10.2.2 Canada Targeted Protein Degradation Drug Market Forecast
10.2.3 Mexico Targeted Protein Degradation Drug Market Forecast
10.2.4 Brazil Targeted Protein Degradation Drug Market Forecast
10.3 APAC Targeted Protein Degradation Drug Forecast by Region (2025-2030)
10.3.1 China Targeted Protein Degradation Drug Market Forecast
10.3.2 Japan Targeted Protein Degradation Drug Market Forecast
10.3.3 Korea Targeted Protein Degradation Drug Market Forecast
10.3.4 Southeast Asia Targeted Protein Degradation Drug Market Forecast
10.3.5 India Targeted Protein Degradation Drug Market Forecast
10.3.6 Australia Targeted Protein Degradation Drug Market Forecast
10.4 Europe Targeted Protein Degradation Drug Forecast by Country (2025-2030)
10.4.1 Germany Targeted Protein Degradation Drug Market Forecast
10.4.2 France Targeted Protein Degradation Drug Market Forecast
10.4.3 UK Targeted Protein Degradation Drug Market Forecast
10.4.4 Italy Targeted Protein Degradation Drug Market Forecast
10.4.5 Russia Targeted Protein Degradation Drug Market Forecast
10.5 Middle East & Africa Targeted Protein Degradation Drug Forecast by Region (2025-2030)
10.5.1 Egypt Targeted Protein Degradation Drug Market Forecast
10.5.2 South Africa Targeted Protein Degradation Drug Market Forecast
10.5.3 Israel Targeted Protein Degradation Drug Market Forecast
10.5.4 Turkey Targeted Protein Degradation Drug Market Forecast
10.5.5 GCC Countries Targeted Protein Degradation Drug Market Forecast
10.6 Global Targeted Protein Degradation Drug Forecast by Type (2025-2030)
10.7 Global Targeted Protein Degradation Drug Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Arvinas
11.1.1 Arvinas Company Information
11.1.2 Arvinas Targeted Protein Degradation Drug Product Offered
11.1.3 Arvinas Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Arvinas Main Business Overview
11.1.5 Arvinas Latest Developments
11.2 Kangpu Biopharmaceuticals
11.2.1 Kangpu Biopharmaceuticals Company Information
11.2.2 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product Offered
11.2.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Kangpu Biopharmaceuticals Main Business Overview
11.2.5 Kangpu Biopharmaceuticals Latest Developments
11.3 Ranok Therapeutics
11.3.1 Ranok Therapeutics Company Information
11.3.2 Ranok Therapeutics Targeted Protein Degradation Drug Product Offered
11.3.3 Ranok Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Ranok Therapeutics Main Business Overview
11.3.5 Ranok Therapeutics Latest Developments
11.4 Accutar Biotechnology
11.4.1 Accutar Biotechnology Company Information
11.4.2 Accutar Biotechnology Targeted Protein Degradation Drug Product Offered
11.4.3 Accutar Biotechnology Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Accutar Biotechnology Main Business Overview
11.4.5 Accutar Biotechnology Latest Developments
11.5 BeiGene Ltd.
11.5.1 BeiGene Ltd. Company Information
11.5.2 BeiGene Ltd. Targeted Protein Degradation Drug Product Offered
11.5.3 BeiGene Ltd. Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BeiGene Ltd. Main Business Overview
11.5.5 BeiGene Ltd. Latest Developments
11.6 Hinova Pharmaceuticals
11.6.1 Hinova Pharmaceuticals Company Information
11.6.2 Hinova Pharmaceuticals Targeted Protein Degradation Drug Product Offered
11.6.3 Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Hinova Pharmaceuticals Main Business Overview
11.6.5 Hinova Pharmaceuticals Latest Developments
11.7 Haisco Pharmaceutical
11.7.1 Haisco Pharmaceutical Company Information
11.7.2 Haisco Pharmaceutical Targeted Protein Degradation Drug Product Offered
11.7.3 Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Haisco Pharmaceutical Main Business Overview
11.7.5 Haisco Pharmaceutical Latest Developments
11.8 Nurix
11.8.1 Nurix Company Information
11.8.2 Nurix Targeted Protein Degradation Drug Product Offered
11.8.3 Nurix Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Nurix Main Business Overview
11.8.5 Nurix Latest Developments
11.9 Kymera Therapeutics
11.9.1 Kymera Therapeutics Company Information
11.9.2 Kymera Therapeutics Targeted Protein Degradation Drug Product Offered
11.9.3 Kymera Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Kymera Therapeutics Main Business Overview
11.9.5 Kymera Therapeutics Latest Developments
11.10 C4 Therapeutics
11.10.1 C4 Therapeutics Company Information
11.10.2 C4 Therapeutics Targeted Protein Degradation Drug Product Offered
11.10.3 C4 Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 C4 Therapeutics Main Business Overview
11.10.5 C4 Therapeutics Latest Developments
12 Research Findings and Conclusion